AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2025
Mar 8, 2025
34576_dirs_2025-03-07_518d2c34-1cbb-41b7-87d5-08c0d786ab33.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2025-03-06
Reporting Person: DeLucia David (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-06 | Common Stock | F | 2325 | $0.39 | Disposed | 116137 | Direct |
Footnotes
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
More from FIBROGEN INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 15
Regulatory Filings
2026
Jun 9
Delisting Announcement
2026
Apr 9
Call Transcript
2026
Mar 16
Call Transcript
2026
Mar 11
Call Transcript
2026
Feb 26
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Board/Management Information
2026
Jan 7
Director's Dealing
2025
Dec 9